Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure

Míreanna comhchosúla

• Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
  de réir: Parry, C, et al.
  Foilsithe / Cruthaithe: (2010)
• Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.
  de réir: Chau, T, et al.
  Foilsithe / Cruthaithe: (2007)
• Cotrimoxazole treats fluoroquinolone-resistant Salmonella typhi H58 infection
  de réir: Karki, M, et al.
  Foilsithe / Cruthaithe: (2016)
• The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy
  de réir: Parry, C, et al.
  Foilsithe / Cruthaithe: (2011)
• The evolution of antimicrobial resistance in Salmonella Typhi
  de réir: Karkey, A, et al.
  Foilsithe / Cruthaithe: (2017)